Comentario Editorial. ¿Se debería seguir utilizando aspirina en prevención primaria?
Leído
3061
Vecesse ha leído el artículo
2353
Total PDF
708
Total HTML
Información del artículo
ISSN: X7351097Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 8 | 11 | 19 |
| 2025 5 | 15 | 18 | 33 |
| 2025 4 | 16 | 18 | 34 |
| 2025 3 | 11 | 22 | 33 |
| 2025 2 | 12 | 21 | 33 |
| 2025 1 | 10 | 10 | 20 |
| 2024 12 | 19 | 12 | 31 |
| 2024 11 | 19 | 18 | 37 |
| 2024 10 | 10 | 31 | 41 |
| 2024 9 | 9 | 28 | 37 |
| 2024 8 | 12 | 31 | 43 |
| 2024 7 | 15 | 26 | 41 |
| 2024 6 | 12 | 30 | 42 |
| 2024 5 | 12 | 21 | 33 |
| 2024 4 | 12 | 38 | 50 |
| 2024 3 | 8 | 24 | 32 |
| 2024 2 | 12 | 28 | 40 |
| 2024 1 | 11 | 56 | 67 |
| 2023 12 | 8 | 24 | 32 |
| 2023 11 | 6 | 40 | 46 |
| 2023 10 | 10 | 48 | 58 |
| 2023 9 | 9 | 32 | 41 |
| 2023 8 | 8 | 28 | 36 |
| 2023 7 | 7 | 26 | 33 |
| 2023 6 | 8 | 27 | 35 |
| 2023 5 | 9 | 31 | 40 |
| 2023 4 | 4 | 16 | 20 |
| 2023 3 | 17 | 22 | 39 |
| 2023 2 | 20 | 19 | 39 |
| 2022 1 | 9 | 7 | 16 |
| 2022 12 | 9 | 12 | 21 |
| 2022 11 | 11 | 17 | 28 |
| 2022 10 | 13 | 12 | 25 |
| 2022 9 | 6 | 11 | 17 |
| 2022 8 | 11 | 18 | 29 |
| 2022 7 | 9 | 19 | 28 |
| 2022 6 | 9 | 22 | 31 |
| 2022 5 | 8 | 22 | 30 |
| 2022 4 | 15 | 17 | 32 |
| 2022 3 | 8 | 10 | 18 |
| 2022 2 | 10 | 17 | 27 |
| 2021 1 | 11 | 50 | 61 |
| 2021 12 | 11 | 39 | 50 |
| 2021 11 | 10 | 25 | 35 |
| 2021 10 | 13 | 32 | 45 |
| 2021 9 | 11 | 29 | 40 |
| 2021 8 | 2 | 22 | 24 |
| 2021 7 | 12 | 31 | 43 |
| 2021 6 | 2 | 22 | 24 |
| 2021 5 | 9 | 29 | 38 |
| 2021 4 | 30 | 94 | 124 |
| 2021 3 | 15 | 35 | 50 |
| 2021 2 | 6 | 30 | 36 |
| 2020 1 | 4 | 18 | 22 |
| 2020 12 | 7 | 15 | 22 |
| 2020 11 | 8 | 16 | 24 |
| 2020 10 | 7 | 25 | 32 |
| 2020 9 | 8 | 41 | 49 |
| 2020 8 | 35 | 74 | 109 |
| 2020 7 | 17 | 59 | 76 |
| 2020 6 | 6 | 25 | 31 |
| 2020 5 | 5 | 28 | 33 |
| 2020 4 | 9 | 44 | 53 |
| 2020 3 | 9 | 118 | 127 |
| 2020 2 | 14 | 512 | 526 |
Mostrar todo
